BioLineRx Ltd. Share Price & Technical Analysis
BLRX · $3.06 (+9.29%)
Healthcare / Biotechnology
$3.06
+9.29%
BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the tre…
Price chart
Seasonality
May has 5 positive and 0 negative years (last 5 years shown)
11% return in May, 36% avg return in past 3 year May month.
19% return in 2026, -35% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 11% | -10% | -15% | 22% | 11% | – | – | – | – | – | – | – | 19% |
| 25 | -61% | -8% | -9% | 13% | 49% | -12% | -13% | 0% | 0% | -8% | -3% | -18% | -70% |
| 24 | -24% | 10% | -16% | -29% | 14% | -24% | 39% | -18% | -18% | -32% | -25% | -30% | -154% |
| 23 | 5% | -3% | 51% | 19% | 46% | 3% | -4% | 14% | 5% | -17% | -6% | 8% | 121% |
| 22 | -13% | -16% | 13% | -28% | 27% | -17% | 3% | 17% | -38% | -8% | -17% | -17% | -93% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Uptrend
BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$13.50M
P/E ratio
—
52W high
$7.77
52W low
$2.15
Volume
55,391
Beta
0.59
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is BioLineRx Ltd. share price today?
- BioLineRx Ltd. (BLRX) last traded around $3.06 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BLRX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BLRX. Download the app for real-time alerts.
- How can I analyze BioLineRx Ltd. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.